Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus

Journal of International Medical Research

Volumn 40, Issue 2, 2012, Pages 709-716

  Stoian, I ^b,c   Savu, O ^a   Ionescu Tirgoviste, C ^a   Atanasiu, V ^b   Gaman, L ^b   Papacocea, R ^b  

^a National Institute of Diabetes   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c R and D IRIST LABMED SRL   (Romania)

Author keywords

Antioxidants; Oxidative stress; Total antioxidant capacity; Type 2 diabetes mellitus

Indexed keywords

2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); ALBUMIN; ANTIOXIDANT; CERULOPLASMIN; COPPER; HEMOGLOBIN A1C; LIPID PEROXIDE; MALONALDEHYDE; ORAL ANTIDIABETIC AGENT; TROLOX C; URIC ACID;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CASE CONTROL STUDY; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; FEMALE; HUMAN; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLASMA RESIDUAL ANTIOXIDANT ACTIVITY; TOTAL PLASMA ANTIOXIDANT CAPACITY;

EID: 84860562856     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000235     Document Type: Article

References (36)

1. van Campenhout A, Van Campenhout C, Lagrou AR, et al: Impact of diabetes mellitus on the relationships between iron-, inflammatory-and oxidative stress status. Diabetes Metab Res Rev 2006; 22: 444-454.
2. Poitout V, Robertson RP: Glucoli potoxicity: fuel excess and β-cell dysfunction. Endocr Rev 2008; 29: 351-366.
3. Li N, Frigerio F, Maechler P: The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem Soc Trans 2008; 36: 930-934.
4. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
5. Nishikawa T, Edelstein D, Du XL, et al: Normalizing mitochondrial super oxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.
6. Aguilar MV, Saavedra P, Arrieta FJ, et al: Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007; 51: 402-406.
7. Raz I, Havivi E: Trace elements in blood cells of diabetic subjects. Diabetes Res 1989; 10: 21-24.
8. Zargar AH, Shah NA, Masoodi SR, et al: Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J 1998; 74: 665-668.
9. Zheng Y, Li XK, Wang Y, et al: The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 2008; 32: 135-145.
10. Bagnati M, Perugini C, Cau C, et al: When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999; 340: 143-152.
11. Liochev SI, Fridovich I: Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase. Free Radic Biol Med 2010; 48: 1565-1569.
12. Ceriello A: Oxidative stress and glycemic regulation. Metabolism 2000; 49: 27-29.
13. Opara EC: Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Health 2002; 122: 28-34.
14. Walter RM Jr, Uriu-Hare JY, Olin KL, et al: Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991; 14: 1050-1056.
15. Eaton JW, Qian M: Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem 2002; 234-235: 135-142.
16. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (suppl 1): S5-S10
17. Miller NJ, Rice-Evans CA: Spectro photometric determination of antioxidant activity. Redox Report 1996, 2: 161-171.
18. Re R, Pellegrini N, Proteggente A, et al: Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26: 1231-1237.
19. Miller NJ, Johnston JD, Collis CS, et al: Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem 1997; 34: 85-90.
20. Schosinsky KH, Lehmann HP, Beeler MF: Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974; 20: 1556-1563.
21. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.
22. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, et al: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995; 44: 1054-1058.
23. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, et al: Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant 1998; 13: 2829-2832.
24. Valkonen M, Kuusi T: Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J Lipid Res 1997; 38: 823-833.
25. Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279-293.
26. Halliwell B, Gutteridge JM: The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995; 18: 125-126.
27. Feillet-Coudray C, Rock E, Coudray C, et al: Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 1999; 284: 31-43.
28. Ogbera AO, Azenabor AO: Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr 2010; 2: 24.
29. Zoppini G, Targher G, Negri C, et al: Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009; 32: 1716-1720.
30. Scott GS, Hooper DC: The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses 2001; 56: 95-100.
31. Sundsten T, Ostenson CG, Bergsten P: Serum protein patterns in newly diagnosed type 2 diabetes mellitus - influence of diabetic environment and family history of diabetes. Diabetes Metab Res Rev 2008; 24: 148-154.
32. Viktorínová A, Toserová E, Krizko M, et al: Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009; 58: 1477-1482.
33. Sato M, Gitlin JD: Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 1991; 266: 5128-5134.
34. Kim IG, Park SY: Requirement of intact human ceruloplasmin for the glutathione-linked peroxidase activity. FEBS Lett 1998; 437: 293-296.
35. Park YS, Suzuki K, Taniguchi N, et al: Glutathione peroxidase-like activity of caeruloplasmin as an important lung antioxidant. FEBS Lett 1999; 458: 133-136.
36. Cooper GJ, Phillips AR, Choong SY, et al: Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004; 53: 2501-2508.